Thomas Boyd Martin

A coming phase-1 study will look at feasibility and safety of Tumor-Treating-Field(TTField) arrays on treatment of locally-advanced stage III non-small cell lung cancer(NSCLC). This array maintains low-intensity alternating electric fields around the tumor, a...

The 2018 EMBRACE II study emphasizes minimizing vaginal mucosal dose during locally advanced cervical cancer brachytherapy. While traditional organs at risk include bladder, rectum, and sigmoid, vaginal mucosa dose has gained attention due to late toxicities...